- Trials with a EudraCT protocol (7)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
7 result(s) found for: Cochlear implant.
Displaying page 1 of 1.
EudraCT Number: 2017-002377-19 | Sponsor Protocol Number: 1456/2017 | Start Date*: 2017-09-15 |
Sponsor Name:Abteilung für Hals-, Nasen- und Ohrenkrankheiten MUW, AKH Wien | ||
Full Title: Triamcinolone levels in cochlear perilymph | ||
Medical condition: In this study triamcinolone acetonide levels after intratympanic application in the perilymph, and serum of patients receiving a cochlear implant will be studied. In patients undergoing a translaby... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-002672-25 | Sponsor Protocol Number: STR001-201 | Start Date*: 2015-11-18 |
Sponsor Name:Strekin AG | ||
Full Title: A Phase II multicenter, placebo-controlled, proof-of-concept study evaluating the safety, and efficacy of intratympanic STR001 thermogel to preserve residual hearing in adults undergoing cochlear ... | ||
Medical condition: Prevention of Hearing Loss after Cochlear Implant Surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003929-34 | Sponsor Protocol Number: AUT042063 | Start Date*: 2016-03-10 | |||||||||||
Sponsor Name:Autifony Therapeutics Limited | |||||||||||||
Full Title: A Pilot Double-blind, Placebo-controlled Crossover Study to Explore the Possible Benefit of AUT00063, an Oral Modulator of Voltage-gated Potassium Channels, in Adult Post-lingual Unilateral Cochlea... | |||||||||||||
Medical condition: Impaired speech understanding in users of cochlear implants | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005002-22 | Sponsor Protocol Number: PROHEARING | Start Date*: 2013-12-06 | |||||||||||
Sponsor Name:Hannover Medical School | |||||||||||||
Full Title: ACEMg mediated hearing preservation in cochlear implant patients receiving different electrode lengths | |||||||||||||
Medical condition: Cochlear implant patients in whom a cochlear implant preserving residual hearing is medically indicated | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004323-33 | Sponsor Protocol Number: AC102-201 | Start Date*: 2022-05-06 |
Sponsor Name:AudioCure Pharma GmbH | ||
Full Title: Phase II, Multi-Center, Randomized, Blinded Study Evaluating the Efficacy, Safety and Tolerability of a Single Intratympanic Dose of AC102 Compared to Oral Steroids for the Treatment of Idiopathic ... | ||
Medical condition: Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL) ISSNHL is most commonly defined as sensorineural hearing loss of 30dB or greater over at least three contiguous audiometric frequencies occurri... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Trial now transitioned) CZ (Trial now transitioned) BG (Prematurely Ended) AT (Trial now transitioned) NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002602-36 | Sponsor Protocol Number: KKSH-127 | Start Date*: 2016-06-21 |
Sponsor Name:Martin-Luther-Universität Halle-Wittenberg | ||
Full Title: Efficacy and safety of high dose glucocorticosteroid treatment for idiopathic sudden sensorineural hearing loss (HODOKORT) | ||
Medical condition: Idiopathic sudden sensorineural hearing loss | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005278-40 | Sponsor Protocol Number: ABR-55752 | Start Date*: 2016-11-29 | |||||||||||
Sponsor Name:Radboudumc | |||||||||||||
Full Title: Molecular imaging before and during (chemo-) radiotherapy in patients with locally advanced Head and Neck, thoracic and pelvic tumors: prognostic and predictive value of 18F-fluoroazomycin arabinos... | |||||||||||||
Medical condition: Head and neck squamous cell carcinoma (HNSCC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
